Laura Sutcliffe
Stock Analyst at Citigroup
(0.45)
# 4,236
Out of 5,115 analysts
9
Total ratings
33.33%
Success rate
-15.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | Initiates: Buy | $22 | $7.28 | +202.20% | 3 | Sep 18, 2025 | |
| RMD ResMed | Initiates: Buy | $330 | $258.31 | +27.75% | 3 | Sep 18, 2025 | |
| ARGX argenx SE | Initiates: Buy | $390 | $840.50 | -53.60% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $33.88 | - | 2 | Dec 20, 2019 |
Telix Pharmaceuticals
Sep 18, 2025
Initiates: Buy
Price Target: $22
Current: $7.28
Upside: +202.20%
ResMed
Sep 18, 2025
Initiates: Buy
Price Target: $330
Current: $258.31
Upside: +27.75%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $840.50
Upside: -53.60%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $33.88
Upside: -